The effect of GM1 Ganglioside on serum NSE activity in patie nts with stroke

张桂莲,吴海琴,房娟芝,张华华,李觉慧
DOI: https://doi.org/10.3969/j.issn.1671-8259.2001.05.011
2001-01-01
Abstract:Objective: To evaluate the effect of GM1 on the patients with stroke. Methods: Serum NSE was measured by using RIA method in 3 groups: General therapy group, GM1 therapy group(40∼60 mg/d, 7∼14 d) and control group. Results: The results showed serum NSE was higher significantly in patients with stroke than that of controls in 48h∼9 d (P < 0.05, P < 0.01). The NSE level was the highest in 3∼4 d, and then reduced gradually in stroke groups. In general therapy group, the NSE arrived to normal level in 10∼14 d, but in GM1 group, the NSE level was lower than that of general therapy level in 3∼14 d (P < 0.05, P < 0.01) and recovered faster. Conclusion: The test of serum NSE level is useful to monitor the course of the disease in stroke; GM1 may reduce the serum NSE by decreasing the secondary injury of neuron, so as to protect brain.
What problem does this paper attempt to address?